Comera Life Sciences Holdings, Inc.
CMRADelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001907685
Comera Life Sciences Holdings, Inc. was delisted in 2026; its insiders filed their last Form 4 on Feb 2, 2024; no institution reported holding it in 13F filings for Q1 2026; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in Comera Life Sciences Holdings, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CMRA is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 0
- 0 vs. Q4 2025
- Shares held
- 0
- 0 vs. Q4 2025
- Total value
- $0
- $0 vs. Q4 2025
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Holders and value by quarter
Institutions reporting CMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 14 | $194.1K |
| Q2 2023 | 11 | $103.2K |
| Q1 2023 | 11 | $189.8K |
| Q4 2022 | 12 | $642.8K |
| Q3 2022 | 16 | $940.8K |
| Q2 2022 | 10 | $710.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Comera Life Sciences Holdings, Inc.; share changes are against Q4 2025.
No institution reported holding CMRA in Q1 2026.